Remove 2020 Remove Medicaid Remove Medicare Remove Prescription Drug Pricing
article thumbnail

Magnolia Regional used price transparency IT to get more CHF patients to fill their prescriptions

Healthcare It News

"Next, we used MedHx to gather complete patient medication history so we could track whether patients in the study had filled their prescriptions," he added. From July 2020 to September 2021, Magnolia Regional studied medication adherence and prescription fill rates for 417 patients with CHF. ADVICE FOR OTHERS.

article thumbnail

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate

Health Law Advisor

1339) reflects the overarching legislative push by members from both sides of the aisle and chambers of Congress to address drug pricing issues through federal fixes to the PBM framework. Unlike the IRA, which targeted the Medicare program, the provisions of S. 1339, adding several new amendments to create the version of S.

article thumbnail

Challenges and Considerations – Transparent Healthcare Pricing

Medval Compliance Blog

Recognizing the mounting attention given to hidden fees and surprise billing, on June 24, 2019, former President Trump signed an executive order (EO) directing the Department of Health and Human Services (and additional agencies) to take steps to improve price and quality transparency in healthcare. Medicare Set-Aside Considerations.

article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. For people enrolled in Medicare Part D, 20% faced over $500 in OOP costs. A cost of $125 or more yields abandonment of at least 50%.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

The Gallup-West Health Poll finds similar massive support for government negotiation specifically for COVID-19 treatment pricing, shown in the third table. adults 18 and older, in English and Spanish, in May 2020. Furthermore, net spending on these expensive “specialty drugs” increased from $8.7 bn for Medicaid.

article thumbnail

Health Provider News

Hall Render

Ezequiel Molina targets expansion of Piedmont’s heart transplant system Grady Health System’s Cole Tatman set the tone for calm in Burn Unit Northside Hospital emergency specialist Trystan Drummond has ‘uncanny’ ability to solve problems, move forward Wellstar Health System to open center for $100M innovation fund in Atlanta Wellstar, Northeast Georgia (..)